Pakistan · Delayed Price · Currency is PKR Hoechst Pakistan Company Description
Hoechst Pakistan Limited engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
The company provides its allergy management, anti-diarrheals, antiemetic, antibiotic, cardiology, consumer healthcare, diabetes, and emergency care products under Flagyl, Clexane, Lantus, Amaryl, Claforan, Haemaccel, Secnidazole forte, Rulid, Targocid, Tavanic, Tarivid, Aventriax, Stemetil, Lasix, Winstor, Tritace, Cordarone, CoAprovel, Aprovel, CoPlavix, Selsun Blue, Apidra, Toujeo, Soliqua, Daonil, Neodipar, Enterogermina, and Plavix brands.
The company was formerly known as Sanofi-Aventis Pakistan Limited and changed its name to Hoechst Pakistan Limited in September 2023.
Hoechst Pakistan Limited was incorporated in 1967 and is headquartered in Karachi, Pakistan.
| Country | Pakistan |
| Founded | 1967 |
| Industry | Pharmaceutical Preparations |
| Employees | 837 |
| CEO | Sajjad Iftikhar |
Contact Details
Address: Plot 23, Korangi industrial Area Karachi, 74900 Pakistan | |
| Phone | 92 21 3506 0221 |
| Website | hoechst.com.pk |
Stock Details
| Ticker Symbol | HPL |
| Exchange | Pakistan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PKR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sajjad Iftikhar | Chief Executive Officer |
| Yasser Pirmuhammad | Chief Financial Officer |
| Saiyed Raza | Chief Operating Officer |